Taysha Gene Therapies, Inc.
TSHA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001806310
In the last 90 days, Taysha Gene Therapies, Inc. insiders filed 0 open-market purchases and 1 sale; 208 institutions reported holding it in 13F filings for Q2 2026, worth $2.03B in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Taysha Gene Therapies, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 54
- −5 vs. Q2 2022
- Shares held
- 13.9M
- −771.5K (−5.2%) vs. Q2 2022
- Total value
- $27.0M
- −$27.7M (−50.6%) vs. Q2 2022
- New holders
- 3
- 11 more added
- Sold out
- 8
- 22 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TSHA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 208 | $2.03B |
| Q1 2026 | 191 | $1.18B |
| Q4 2025 | 195 | $1.48B |
| Q3 2025 | 155 | $865.6M |
| Q2 2025 | 150 | $595.4M |
| Q1 2025 | 127 | $232.0M |
| Q4 2024 | 131 | $289.8M |
| Q3 2024 | 119 | $315.5M |
| Q2 2024 | 107 | $354.3M |
| Q1 2024 | 109 | $402.2M |
| Q4 2023 | 87 | $230.3M |
| Q3 2023 | 63 | $410.6M |
| Q2 2023 | 39 | $9.05M |
| Q1 2023 | 44 | $13.3M |
| Q4 2022 | 52 | $43.8M |
| Q3 2022 | 54 | $27.0M |
| Q2 2022 | 59 | $54.7M |
| Q1 2022 | 71 | $110.9M |
| Q4 2021 | 65 | $215.6M |
| Q3 2021 | 48 | $361.9M |
| Q2 2021 | 49 | $388.6M |
| Q1 2021 | 46 | $358.5M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Taysha Gene Therapies, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 3,285,783 | $6.34M | 0.00% | −9,906−0.3% | Reduced |
| Nantahala Capital Management, LLC | 1,610,822 | $3.25M | 0.32% | −32,616−2.0% | Reduced |
| Vanguard Group Inc | 1,070,802 | $2.07M | 0.00% | 00.0% | Unchanged |
| Artal Group S.A. | 1,040,882 | $2.01M | 0.10% | 00.0% | Unchanged |
| BlackRock Inc. | 1,035,649 | $2.00M | 0.00% | −10,841−1.0% | Reduced |
| Franklin Resources Inc | 811,069 | $1.56M | 0.00% | 00.0% | Unchanged |
| Sands Capital Ventures, LLC | 724,873 | $1.40M | 0.41% | 00.0% | Unchanged |
| Alphabet Inc. | 640,882 | $1.24M | 0.06% | 00.0% | Unchanged |
| Tybourne Capital Management (HK) Ltd | 500,000 | $965.0K | 0.09% | 00.0% | Unchanged |
| Laurion Capital Management LP | 442,600 | $854.0K | 0.02% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 418,500 | $808.0K | 0.00% | −105,100−20.1% | Reduced |
| Geode Capital Management, LLC | 240,415 | $464.0K | 0.00% | +2,176+0.9% | Added |
| Gsa Capital Partners LLP | 236,120 | $456.0K | 0.06% | +49,640+26.6% | Added |
| Quantum Private Wealth, LLC | 229,069 | $442.0K | 0.28% | +71,295+45.2% | Added |
| Carlson Capital L P | 200,000 | $386.0K | 0.03% | +35,000+21.2% | Added |
| Millennium Management LLC | 174,378 | $337.0K | 0.00% | −41,790−19.3% | Reduced |
| Bridgeway Capital Management, LLC | 139,869 | $270.0K | 0.01% | +69,060+97.5% | Added |
| D. E. Shaw & Co., Inc. | 107,274 | $207.0K | 0.00% | −27,311−20.3% | Reduced |
| Two Sigma Advisers, LP | 87,700 | $169.0K | 0.00% | −18,100−17.1% | Reduced |
| State of Wisconsin Investment Board | 86,600 | $167.0K | 0.00% | −23,900−21.6% | Reduced |
| State Street Corp | 77,420 | $149.0K | 0.00% | 00.0% | Unchanged |
| Ergoteles LLC | 76,743 | $148.0K | 0.01% | −15,057−16.4% | Reduced |
| Bank of America Corp | 69,505 | $134.0K | 0.00% | +3,462+5.2% | Added |
| Thompson Siegel & Walmsley LLC | 56,100 | $108.0K | 0.00% | 00.0% | Unchanged |
| Cornercap Investment Counsel Inc | 54,353 | $105.0K | 0.02% | +14,597+36.7% | Added |
| Acadian Asset Management LLC | 53,447 | $102.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 50,580 | $97.0K | 0.00% | −60,011−54.3% | Reduced |
| Barclays PLC | 47,879 | $97.0K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 44,558 | $86.0K | 0.00% | −234,733−84.0% | Reduced |
| Goldman Sachs Group Inc | 43,483 | $84.0K | 0.00% | −25,796−37.2% | Reduced |
| Two Sigma Investments, LP | 43,378 | $84.0K | 0.00% | −24,266−35.9% | Reduced |
| Northern Trust Corp | 39,927 | $77.0K | 0.00% | +1,106+2.8% | Added |
| Morgan Stanley | 24,962 | $48.0K | 0.00% | −46,689−65.2% | Reduced |
| Sargent Investment Group, LLC | 25,242 | $47.0K | 0.01% | +7,454+41.9% | Added |
| Charles Schwab Investment Management Inc | 16,140 | $32.0K | 0.00% | −74,571−82.2% | Reduced |
| HSBC Holdings PLC | 16,570 | $32.0K | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 16,000 | $31.0K | 0.00% | −1,836−10.3% | Reduced |
| Occudo Quantitative Strategies LP | 14,679 | $28.0K | 0.00% | −16,351−52.7% | Reduced |
| RBF Capital, LLC | 13,800 | $27.0K | 0.00% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 11,000 | $22.0K | 0.00% | −13,100−54.4% | Reduced |
| Bank of New York Mellon Corp | 11,295 | $22.0K | 0.00% | −375−3.2% | Reduced |
| 683 Capital Management, LLC | 10,000 | $19.0K | 0.00% | 00.0% | Unchanged |
| Bordeaux Wealth Advisors LLC | 10,000 | $19.0K | 0.01% | +10,000 | New |
| Tower Research Capital LLC (TRC) | 9,363 | $18.0K | 0.00% | +6,104+187.3% | Added |
| UBS Group AG | 6,272 | $12.0K | 0.00% | −88,288−93.4% | Reduced |
| Allworth Financial LP | 1,000 | $2.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 950 | $2.00K | 0.00% | +787+482.8% | Added |
| Citigroup Inc | 635 | $1.00K | 0.00% | −523−45.2% | Reduced |
| Quantbot Technologies LP | 829 | $1.00K | 0.00% | 00.0% | Unchanged |
| Truvestments Capital LLC | 380 | $1.00K | 0.00% | 00.0% | Unchanged |
| China Universal Asset Management Co., Ltd. | 385 | $1.00K | 0.00% | +385 | New |
| Royal Bank of Canada | 19 | $0 | 0.00% | −1,000−98.1% | Reduced |
| Daiwa Securities Group Inc. | 112 | $0 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 347 | $0 | 0.00% | +347 | New |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −91,670−100.0% | Sold out |
| Davenport & Co LLC | 0 | $0 | 0.00% | −27,170−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −21,163−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −19,548−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −10,134−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −821−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −191−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −12−100.0% | Sold out |